Veru Inc. is an Oncology and Urology Biopharmaceutical Company Developing and Commercializing Novel Medicines for Prostate Cancer and Urology Specialty Pharmaceuticals.
June 2, 2020
Watch the replay of our presentation at the Jefferies 2020 Healthcare Conference on June 2, 2020
PARTICIPANT DIAL IN (TOLL FREE): 1-800-341-1602
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-6706
Please ask to be joined into the Veru Inc call.
May 13, 2020
Listen to other presentations and conference calls
Jun 29, 2020
Veru Inc. Added to the Russell 2000 and 3000 Indices
Jun 19, 2020
Veru Enrolls First Patient in Phase 2 Clinical Trial of Novel Drug, VERU-111, to Combat COVID-19